カテゴリ： 世界, 医療/バイオ, QYResearch

ウイルス性喘息治療の世界市場2023年：経口、注射

■ 英語タイトル：Global Virus-Induced Asthma Treatment Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7573）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7573
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：92
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥435,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥652,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥870,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ウイルス性喘息治療の世界市場2023年：経口、注射]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料はウイルス性喘息治療のグローバル市場について調査・分析し、世界のウイルス性喘息治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（経口、注射）、用途別セグメント分析（病院、クリニック、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、AstraZeneca plc、Sanofi SA、Novartis AG、Mylan NV、Regeneron、F.Hoffman-La Roche Ltd.、Teva Pharmaceuticals Industries Ltd.、Merck & Co.、Cipla Limited、GlaxoSmithKline plc.などが含まれています。ウイルス性喘息治療のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、ウイルス性喘息治療市場規模を算出する際に考慮しました。

・ウイルス性喘息治療市場の概要
- ウイルス性喘息治療の種類別セグメント
- 世界のウイルス性喘息治療市場規模：タイプ別分析（経口、注射）
- ウイルス性喘息治療の用途別セグメント
- 世界のウイルス性喘息治療市場規模：用途別分析（病院、クリニック、その他）
- 世界のウイルス性喘息治療市場規模予測（2018年-2029年）

・ウイルス性喘息治療市場の成長トレンド
- ウイルス性喘息治療の地域別市場規模（2018年-2029年）
- ウイルス性喘息治療市場ダイナミクス
- ウイルス性喘息治療の業界動向
- ウイルス性喘息治療市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：経口、注射
- 世界のウイルス性喘息治療のタイプ別市場規模（2018年-2023年）
- 世界のウイルス性喘息治療のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、クリニック、その他
- 世界のウイルス性喘息治療の用途別市場規模（2018年-2023年）
- 世界のウイルス性喘息治療の用途別市場規模（2024年-2029年）

・ウイルス性喘息治療の地域別市場規模
- 北米のウイルス性喘息治療市場規模（2018年-2029年）
- 米国のウイルス性喘息治療市場規模（2018年-2029年）
- ヨーロッパのウイルス性喘息治療市場規模（2018年-2029年）
- アジア太平洋のウイルス性喘息治療市場規模（2018年-2029年）
- 中国のウイルス性喘息治療市場規模（2018年-2029年）
- 日本のウイルス性喘息治療市場規模（2018年-2029年）
- 韓国のウイルス性喘息治療市場規模（2018年-2029年）
- インドのウイルス性喘息治療市場規模（2018年-2029年）
- オーストラリアのウイルス性喘息治療市場規模（2018年-2029年）
- 中南米のウイルス性喘息治療市場規模（2018年-2029年）
- 中東・アフリカのウイルス性喘息治療市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
AstraZeneca plc、Sanofi SA、Novartis AG、Mylan NV、Regeneron、F.Hoffman-La Roche Ltd.、Teva Pharmaceuticals Industries Ltd.、Merck & Co.、Cipla Limited、GlaxoSmithKline plc.

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Virus-Induced Asthma Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Virus-Induced Asthma Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Virus-Induced Asthma Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Virus-Induced Asthma Treatment in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Virus-Induced Asthma Treatment include AstraZeneca plc, Sanofi SA, Novartis AG, Mylan NV, Regeneron, F.Hoffman-La Roche Ltd., Teva Pharmaceuticals Industries Ltd., Merck & Co. and Cipla Limited, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Virus-Induced Asthma Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Virus-Induced Asthma Treatment.
The Virus-Induced Asthma Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Virus-Induced Asthma Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Virus-Induced Asthma Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
AstraZeneca plc
Sanofi SA
Novartis AG
Mylan NV
Regeneron
F.Hoffman-La Roche Ltd.
Teva Pharmaceuticals Industries Ltd.
Merck & Co.
Cipla Limited
GlaxoSmithKline plc.
Segment by Type
Oral
Injection
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Virus-Induced Asthma Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Virus-Induced Asthma Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Virus-Induced Asthma Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Virus-Induced Asthma Treatment Market Perspective (2018-2029)
2.2 Virus-Induced Asthma Treatment Growth Trends by Region
2.2.1 Global Virus-Induced Asthma Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Virus-Induced Asthma Treatment Historic Market Size by Region (2018-2023)
2.2.3 Virus-Induced Asthma Treatment Forecasted Market Size by Region (2024-2029)
2.3 Virus-Induced Asthma Treatment Market Dynamics
2.3.1 Virus-Induced Asthma Treatment Industry Trends
2.3.2 Virus-Induced Asthma Treatment Market Drivers
2.3.3 Virus-Induced Asthma Treatment Market Challenges
2.3.4 Virus-Induced Asthma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Virus-Induced Asthma Treatment Players by Revenue
3.1.1 Global Top Virus-Induced Asthma Treatment Players by Revenue (2018-2023)
3.1.2 Global Virus-Induced Asthma Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Virus-Induced Asthma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Virus-Induced Asthma Treatment Revenue
3.4 Global Virus-Induced Asthma Treatment Market Concentration Ratio
3.4.1 Global Virus-Induced Asthma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Virus-Induced Asthma Treatment Revenue in 2022
3.5 Virus-Induced Asthma Treatment Key Players Head office and Area Served
3.6 Key Players Virus-Induced Asthma Treatment Product Solution and Service
3.7 Date of Enter into Virus-Induced Asthma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Virus-Induced Asthma Treatment Breakdown Data by Type
4.1 Global Virus-Induced Asthma Treatment Historic Market Size by Type (2018-2023)
4.2 Global Virus-Induced Asthma Treatment Forecasted Market Size by Type (2024-2029)
5 Virus-Induced Asthma Treatment Breakdown Data by Application
5.1 Global Virus-Induced Asthma Treatment Historic Market Size by Application (2018-2023)
5.2 Global Virus-Induced Asthma Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Virus-Induced Asthma Treatment Market Size (2018-2029)
6.2 North America Virus-Induced Asthma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Virus-Induced Asthma Treatment Market Size by Country (2018-2023)
6.4 North America Virus-Induced Asthma Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Virus-Induced Asthma Treatment Market Size (2018-2029)
7.2 Europe Virus-Induced Asthma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Virus-Induced Asthma Treatment Market Size by Country (2018-2023)
7.4 Europe Virus-Induced Asthma Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Virus-Induced Asthma Treatment Market Size (2018-2029)
8.2 Asia-Pacific Virus-Induced Asthma Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Virus-Induced Asthma Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Virus-Induced Asthma Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Virus-Induced Asthma Treatment Market Size (2018-2029)
9.2 Latin America Virus-Induced Asthma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Virus-Induced Asthma Treatment Market Size by Country (2018-2023)
9.4 Latin America Virus-Induced Asthma Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Virus-Induced Asthma Treatment Market Size (2018-2029)
10.2 Middle East & Africa Virus-Induced Asthma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Virus-Induced Asthma Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Virus-Induced Asthma Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca plc
11.1.1 AstraZeneca plc Company Detail
11.1.2 AstraZeneca plc Business Overview
11.1.3 AstraZeneca plc Virus-Induced Asthma Treatment Introduction
11.1.4 AstraZeneca plc Revenue in Virus-Induced Asthma Treatment Business (2018-2023)
11.1.5 AstraZeneca plc Recent Development
11.2 Sanofi SA
11.2.1 Sanofi SA Company Detail
11.2.2 Sanofi SA Business Overview
11.2.3 Sanofi SA Virus-Induced Asthma Treatment Introduction
11.2.4 Sanofi SA Revenue in Virus-Induced Asthma Treatment Business (2018-2023)
11.2.5 Sanofi SA Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Detail
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Virus-Induced Asthma Treatment Introduction
11.3.4 Novartis AG Revenue in Virus-Induced Asthma Treatment Business (2018-2023)
11.3.5 Novartis AG Recent Development
11.4 Mylan NV
11.4.1 Mylan NV Company Detail
11.4.2 Mylan NV Business Overview
11.4.3 Mylan NV Virus-Induced Asthma Treatment Introduction
11.4.4 Mylan NV Revenue in Virus-Induced Asthma Treatment Business (2018-2023)
11.4.5 Mylan NV Recent Development
11.5 Regeneron
11.5.1 Regeneron Company Detail
11.5.2 Regeneron Business Overview
11.5.3 Regeneron Virus-Induced Asthma Treatment Introduction
11.5.4 Regeneron Revenue in Virus-Induced Asthma Treatment Business (2018-2023)
11.5.5 Regeneron Recent Development
11.6 F.Hoffman-La Roche Ltd.
11.6.1 F.Hoffman-La Roche Ltd. Company Detail
11.6.2 F.Hoffman-La Roche Ltd. Business Overview
11.6.3 F.Hoffman-La Roche Ltd. Virus-Induced Asthma Treatment Introduction
11.6.4 F.Hoffman-La Roche Ltd. Revenue in Virus-Induced Asthma Treatment Business (2018-2023)
11.6.5 F.Hoffman-La Roche Ltd. Recent Development
11.7 Teva Pharmaceuticals Industries Ltd.
11.7.1 Teva Pharmaceuticals Industries Ltd. Company Detail
11.7.2 Teva Pharmaceuticals Industries Ltd. Business Overview
11.7.3 Teva Pharmaceuticals Industries Ltd. Virus-Induced Asthma Treatment Introduction
11.7.4 Teva Pharmaceuticals Industries Ltd. Revenue in Virus-Induced Asthma Treatment Business (2018-2023)
11.7.5 Teva Pharmaceuticals Industries Ltd. Recent Development
11.8 Merck & Co.
11.8.1 Merck & Co. Company Detail
11.8.2 Merck & Co. Business Overview
11.8.3 Merck & Co. Virus-Induced Asthma Treatment Introduction
11.8.4 Merck & Co. Revenue in Virus-Induced Asthma Treatment Business (2018-2023)
11.8.5 Merck & Co. Recent Development
11.9 Cipla Limited
11.9.1 Cipla Limited Company Detail
11.9.2 Cipla Limited Business Overview
11.9.3 Cipla Limited Virus-Induced Asthma Treatment Introduction
11.9.4 Cipla Limited Revenue in Virus-Induced Asthma Treatment Business (2018-2023)
11.9.5 Cipla Limited Recent Development
11.10 GlaxoSmithKline plc.
11.10.1 GlaxoSmithKline plc. Company Detail
11.10.2 GlaxoSmithKline plc. Business Overview
11.10.3 GlaxoSmithKline plc. Virus-Induced Asthma Treatment Introduction
11.10.4 GlaxoSmithKline plc. Revenue in Virus-Induced Asthma Treatment Business (2018-2023)
11.10.5 GlaxoSmithKline plc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Virus-Induced Asthma Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Global Virus-Induced Asthma Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Virus-Induced Asthma Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Virus-Induced Asthma Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Virus-Induced Asthma Treatment Market Share by Region (2018-2023)
Table 8. Global Virus-Induced Asthma Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Virus-Induced Asthma Treatment Market Share by Region (2024-2029)
Table 10. Virus-Induced Asthma Treatment Market Trends
Table 11. Virus-Induced Asthma Treatment Market Drivers
Table 12. Virus-Induced Asthma Treatment Market Challenges
Table 13. Virus-Induced Asthma Treatment Market Restraints
Table 14. Global Virus-Induced Asthma Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Virus-Induced Asthma Treatment Market Share by Players (2018-2023)
Table 16. Global Top Virus-Induced Asthma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virus-Induced Asthma Treatment as of 2022)
Table 17. Ranking of Global Top Virus-Induced Asthma Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Virus-Induced Asthma Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Virus-Induced Asthma Treatment Product Solution and Service
Table 21. Date of Enter into Virus-Induced Asthma Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Virus-Induced Asthma Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Virus-Induced Asthma Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Virus-Induced Asthma Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Virus-Induced Asthma Treatment Revenue Market Share by Type (2024-2029)
Table 27. Global Virus-Induced Asthma Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Virus-Induced Asthma Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Virus-Induced Asthma Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Virus-Induced Asthma Treatment Revenue Market Share by Application (2024-2029)
Table 31. North America Virus-Induced Asthma Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Virus-Induced Asthma Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Virus-Induced Asthma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Virus-Induced Asthma Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Virus-Induced Asthma Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Virus-Induced Asthma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Virus-Induced Asthma Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Virus-Induced Asthma Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Virus-Induced Asthma Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Virus-Induced Asthma Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Virus-Induced Asthma Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Virus-Induced Asthma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Virus-Induced Asthma Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Virus-Induced Asthma Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Virus-Induced Asthma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 46. AstraZeneca plc Company Detail
Table 47. AstraZeneca plc Business Overview
Table 48. AstraZeneca plc Virus-Induced Asthma Treatment Product
Table 49. AstraZeneca plc Revenue in Virus-Induced Asthma Treatment Business (2018-2023) & (US$ Million)
Table 50. AstraZeneca plc Recent Development
Table 51. Sanofi SA Company Detail
Table 52. Sanofi SA Business Overview
Table 53. Sanofi SA Virus-Induced Asthma Treatment Product
Table 54. Sanofi SA Revenue in Virus-Induced Asthma Treatment Business (2018-2023) & (US$ Million)
Table 55. Sanofi SA Recent Development
Table 56. Novartis AG Company Detail
Table 57. Novartis AG Business Overview
Table 58. Novartis AG Virus-Induced Asthma Treatment Product
Table 59. Novartis AG Revenue in Virus-Induced Asthma Treatment Business (2018-2023) & (US$ Million)
Table 60. Novartis AG Recent Development
Table 61. Mylan NV Company Detail
Table 62. Mylan NV Business Overview
Table 63. Mylan NV Virus-Induced Asthma Treatment Product
Table 64. Mylan NV Revenue in Virus-Induced Asthma Treatment Business (2018-2023) & (US$ Million)
Table 65. Mylan NV Recent Development
Table 66. Regeneron Company Detail
Table 67. Regeneron Business Overview
Table 68. Regeneron Virus-Induced Asthma Treatment Product
Table 69. Regeneron Revenue in Virus-Induced Asthma Treatment Business (2018-2023) & (US$ Million)
Table 70. Regeneron Recent Development
Table 71. F.Hoffman-La Roche Ltd. Company Detail
Table 72. F.Hoffman-La Roche Ltd. Business Overview
Table 73. F.Hoffman-La Roche Ltd. Virus-Induced Asthma Treatment Product
Table 74. F.Hoffman-La Roche Ltd. Revenue in Virus-Induced Asthma Treatment Business (2018-2023) & (US$ Million)
Table 75. F.Hoffman-La Roche Ltd. Recent Development
Table 76. Teva Pharmaceuticals Industries Ltd. Company Detail
Table 77. Teva Pharmaceuticals Industries Ltd. Business Overview
Table 78. Teva Pharmaceuticals Industries Ltd. Virus-Induced Asthma Treatment Product
Table 79. Teva Pharmaceuticals Industries Ltd. Revenue in Virus-Induced Asthma Treatment Business (2018-2023) & (US$ Million)
Table 80. Teva Pharmaceuticals Industries Ltd. Recent Development
Table 81. Merck & Co. Company Detail
Table 82. Merck & Co. Business Overview
Table 83. Merck & Co. Virus-Induced Asthma Treatment Product
Table 84. Merck & Co. Revenue in Virus-Induced Asthma Treatment Business (2018-2023) & (US$ Million)
Table 85. Merck & Co. Recent Development
Table 86. Cipla Limited Company Detail
Table 87. Cipla Limited Business Overview
Table 88. Cipla Limited Virus-Induced Asthma Treatment Product
Table 89. Cipla Limited Revenue in Virus-Induced Asthma Treatment Business (2018-2023) & (US$ Million)
Table 90. Cipla Limited Recent Development
Table 91. GlaxoSmithKline plc. Company Detail
Table 92. GlaxoSmithKline plc. Business Overview
Table 93. GlaxoSmithKline plc. Virus-Induced Asthma Treatment Product
Table 94. GlaxoSmithKline plc. Revenue in Virus-Induced Asthma Treatment Business (2018-2023) & (US$ Million)
Table 95. GlaxoSmithKline plc. Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Virus-Induced Asthma Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Virus-Induced Asthma Treatment Market Share by Type: 2022 VS 2029
Figure 3. Oral Features
Figure 4. Injection Features
Figure 5. Global Virus-Induced Asthma Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Virus-Induced Asthma Treatment Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Virus-Induced Asthma Treatment Report Years Considered
Figure 11. Global Virus-Induced Asthma Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Virus-Induced Asthma Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Virus-Induced Asthma Treatment Market Share by Region: 2022 VS 2029
Figure 14. Global Virus-Induced Asthma Treatment Market Share by Players in 2022
Figure 15. Global Top Virus-Induced Asthma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virus-Induced Asthma Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Virus-Induced Asthma Treatment Revenue in 2022
Figure 17. North America Virus-Induced Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Virus-Induced Asthma Treatment Market Share by Country (2018-2029)
Figure 19. United States Virus-Induced Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Virus-Induced Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Virus-Induced Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Virus-Induced Asthma Treatment Market Share by Country (2018-2029)
Figure 23. Germany Virus-Induced Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Virus-Induced Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Virus-Induced Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Virus-Induced Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Virus-Induced Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Virus-Induced Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Virus-Induced Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Virus-Induced Asthma Treatment Market Share by Region (2018-2029)
Figure 31. China Virus-Induced Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Virus-Induced Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Virus-Induced Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Virus-Induced Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Virus-Induced Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Virus-Induced Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Virus-Induced Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Virus-Induced Asthma Treatment Market Share by Country (2018-2029)
Figure 39. Mexico Virus-Induced Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Virus-Induced Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Virus-Induced Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Virus-Induced Asthma Treatment Market Share by Country (2018-2029)
Figure 43. Turkey Virus-Induced Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Virus-Induced Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. AstraZeneca plc Revenue Growth Rate in Virus-Induced Asthma Treatment Business (2018-2023)
Figure 46. Sanofi SA Revenue Growth Rate in Virus-Induced Asthma Treatment Business (2018-2023)
Figure 47. Novartis AG Revenue Growth Rate in Virus-Induced Asthma Treatment Business (2018-2023)
Figure 48. Mylan NV Revenue Growth Rate in Virus-Induced Asthma Treatment Business (2018-2023)
Figure 49. Regeneron Revenue Growth Rate in Virus-Induced Asthma Treatment Business (2018-2023)
Figure 50. F.Hoffman-La Roche Ltd. Revenue Growth Rate in Virus-Induced Asthma Treatment Business (2018-2023)
Figure 51. Teva Pharmaceuticals Industries Ltd. Revenue Growth Rate in Virus-Induced Asthma Treatment Business (2018-2023)
Figure 52. Merck & Co. Revenue Growth Rate in Virus-Induced Asthma Treatment Business (2018-2023)
Figure 53. Cipla Limited Revenue Growth Rate in Virus-Induced Asthma Treatment Business (2018-2023)
Figure 54. GlaxoSmithKline plc. Revenue Growth Rate in Virus-Induced Asthma Treatment Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 好酸球性喘息治療薬の世界市場2023年：静脈内注射、皮下注射
  • 結晶性関節炎治療の世界市場2023年：経口剤、注射剤
  • ヘパリン誘発性血小板減少症治療の世界市場2023年：活性化因子 X 阻害剤 ヘパリン誘発性血小板減少症治療、直接トロンビン阻害剤 ヘパリン誘発性血小板減少症治療、ヘパリノイド ヘパリン誘発性血小板減少症治療、フォンダパリヌクス ヘパリン誘発性血小板減少症治療、ヘパリン＆ビタミン K アンタゴニスト療法 ヘパリン誘発性血小板減少症治療
  • 好酸球性喘息治療薬のグローバル市場展望 2023年-2029年：点滴静注型、皮下注射型
  • 薬物誘発性腎毒性治療の世界市場インサイト・予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7573 )"ウイルス性喘息治療の世界市場2023年：経口、注射" (英文：Global Virus-Induced Asthma Treatment Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。